RETRACTED ARTICLE: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment

por Oya, Mototsugu, Kaneko, Shuichi, Imai, Tsuneo, Tsujino, Toshiaki, Sunaya, Toshiyuki, Okayama, Yutaka
Publicado 2022

A rapid and durable response to larotrectinib in a patient with NTRK fusion-positive secretory carcinoma originating from the external auditory canal

por Ando, Yuichi, Morita, Sachi, Shimokata, Tomoya, Tsuzuki, Toyonori, Inafuku, Shigeru, Iwami, Kenichiro, Brega, Nicoletta, Akagawa, Takashi, Tsujino, Toshiaki, Ogawa, Tetsuya
Publicado 2022

Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study

por Fukuhara, Noriko, Maruyama, Dai, Hatake, Kiyohiko, Nagai, Hirokazu, Makita, Shinichi, Kamezaki, Kenjiro, Uchida, Toshiki, Kusumoto, Shigeru, Kuroda, Junya, Iriyama, Chisako, Yanada, Masamitsu, Tsukamoto, Norifumi, Suehiro, Youko, Minami, Hironobu, Garcia-Vargas, Jose, Childs, Barrett H., Yasuda, Masanobu, Masuda, Shigeo, Tsujino, Toshiaki, Terao, Yui, Tobinai, Kensei
Publicado 2022